Literature DB >> 18670866

Partial dissociation of TSC2 and mTOR phosphorylation in cardiac and skeletal muscle of rats in vivo.

Sara Forsyth1, Thomas C Vary.   

Abstract

Insulin promotes protein accretion in cardiac and skeletal muscles through a stimulation of the mRNA translation initiation phase of protein synthesis. The present set of experiments examined the regulatory TSC2 signaling pathway that potentially contributes to the myocardial responsiveness of protein synthesis to insulin in post-absorptive male Sprague-Dawley rats in vivo. Heart and skeletal muscles were sampled from rats up to 1 h following intravenous injection of various doses of insulin. In cardiac muscle, TSC2 phosphorylation was elevated only at the highest plasma insulin concentration (386 ng/ml). In contrast, the extent of mTOR phosphorylation either on Ser((2448)) or Ser((2481)) was raised at 24-fold less concentration of insulin and corresponded with increased phosphorylation of PKB(Thr(308)) or PKB(Ser(473)). In gastrocnemius, TSC2 phosphorylation was elevated at plasma insulin concentrations (16 ng/ml) lower than that observed in cardiac muscle (386 ng insulin/ml). The increased TSC2 phosphorylation corresponded with a marked stimulation of PKB phosphorylation. However, mTOR(Ser(2448)) or mTOR(Ser(2481)) phosphorylation was not elevated until the plasma insulin concentration reached 97 ng/ml. The results indicate there is a dissociation of TSC2 and mTOR phosphorylation in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670866      PMCID: PMC2774784          DOI: 10.1007/s11010-008-9887-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  23 in total

Review 1.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions.

Authors:  R T Peterson; P A Beal; M J Comb; S L Schreiber
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  IGF-I activates the eIF4F system in cardiac muscle in vivo.

Authors:  Thomas C Vary; Charles H Lang
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

Review 4.  Insulin signal transduction through protein kinase cascades.

Authors:  J Avruch
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

5.  Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

Authors:  B T Navé; M Ouwens; D J Withers; D R Alessi; P R Shepherd
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

6.  Meal feeding stimulates phosphorylation of multiple effector proteins regulating protein synthetic processes in rat hearts.

Authors:  Thomas C Vary; Christopher J Lynch
Journal:  J Nutr       Date:  2006-09       Impact factor: 4.798

7.  A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells.

Authors:  A Sekulić; C C Hudson; J L Homme; P Yin; D M Otterness; L M Karnitz; R T Abraham
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  Chronic alcohol feeding impairs mTOR(Ser 2448) phosphorylation in rat hearts.

Authors:  Thomas C Vary; Gina Deiter; Rachel Lantry
Journal:  Alcohol Clin Exp Res       Date:  2007-11-20       Impact factor: 3.455

Review 9.  Nutrient signaling components controlling protein synthesis in striated muscle.

Authors:  Thomas C Vary; Christopher J Lynch
Journal:  J Nutr       Date:  2007-08       Impact factor: 4.798

10.  Rapamycin limits formation of active eukaryotic initiation factor 4F complex following meal feeding in rat hearts.

Authors:  Thomas C Vary; Gina Deiter; Christopher J Lynch
Journal:  J Nutr       Date:  2007-08       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.